Pulmonary arterial hypertension trials in Hungary

In Hungary 8 Also abroad 305

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Where
Budapest
Age
2 years and over
People
280 worldwide
Run by
Actelion
See details and how to joinNCT05179876 · EU 2023-506791-27-00
Phase 4Taking people
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Where
Budapest, Budapest VIII, Szeged
Age
18 years to 75 years
People
110 worldwide
Run by
AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06317805 · EU 2023-504351-26-01
Phase 3Taking people
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Where
Budapest
Age
Up to 18 years
People
20 worldwide
Run by
AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06350032 · EU 2023-505082-91-00
No phaseEnrolling by invitation
A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients
Where
Budapest, Szeged
Age
18 years and over
People
110 worldwide
Run by
AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06445673
Phase 1/2Taking people
Phase 1b/2 Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIde)
Where
Budapest VIII, Szeged
Age
18 years and over
People
50 worldwide
Run by
35Pharma Inc.
See details and how to join2025-523010-89-00 · EU 2025-523010-89-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Where
Budapest Viii, Szeged
Age
18 years to 75 years
People
344 worldwide
Run by
Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00
Phase 3Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Budapest, Pécs, Szeged
Age
18 years and over
People
1,000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
No phaseTaking people
Cardiovascular Risk in Children With Chronic Conditions Study
Where
Budapest
Age
6 years to 25 years
People
300
Run by
Semmelweis University
See details and how to joinNCT07086989